On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Long-term Semaglutide Leads to Continued Weight Loss Versus Placebo
March 31st 2021Patients who continued taking semaglutide (Rybelsus/Novo Nordisk) after an initial 20-week therapy period saw continued weight loss, leading to the hope that a new pharmacologic approach to weight loss could be on the horizon.
Improving the Accessibility of Naloxone and Potential Impact
Joshua Lynch, DO, EMT-P, FAAEM, FACEP, shares ways to improve naloxone accessibility, and Theresa Mallick-Searle, MS, RN-BC, ANP-BC, discusses stigmatization.
Implementing Protocols, Policies, and Programs to Save Lives
Experts weigh in on protocols, policies, and programs that influence patient safety and address when a conversation should ensue with patients about naloxone.
Role of Early Treatment and Gaps in Heart Failure Diagnosis
The role of early aggressive treatment in preventing progression of heart failures and the importance of understanding the root cause of disease.